Cadila Healthcare informs about company updates

07 Aug 2019 Evaluate

Cadila Healthcare has informed that the US FDA classifies the inspection of the Company’s Moraiya unit as OAI.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

349.05 3.90 (1.13%)
May 17, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 892.05
Cipla 938.00
Dr. Reddy's Lab 3904.10
Aurobindo Pharma 536.05
Lupin 691.40
View more..